Tag: biotechnology
-
RNA-Nanoparticle Spray Protects Against Plant Viruses
Plant scientists combined synthetic genetic material with clay nanoparticles, which when sprayed on plants provides enduring protection against viruses.
-
Sanofi Licensing Antibody for Autoimmune Diseases
The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College.
-
Ionis Options Cardiac Drugs in $1.5 Billion Deal
Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease.
-
Precision Health Tech Network Expands, Invests $400M
Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network.
-
Gene Expression Changes Found in Wound Healing Therapy
A clinical trial to reveal the mechanism of a cell therapy to treat venous skin ulcers found the therapy works by altering the gene expression activity of treated cells to resemble healthy tissue.
-
Biotech, Pharma Partner on Neuro Drug Discovery
A collaboration between a biotechnology enterprise tracking defective proteins and pharmaceutical company plans to discover new treatments for neurodegenerative disorders.
-
Antibody Trials Stopped After Deaths Reported
The U.S. Food and Drug Administration halted early-stage clinical trials of a monoclonal antibody drug for leukemia after four deaths occurred from liver toxicity.
-
Trial to Test Stem Cells for Treating Heart Failure
A clinical trial testing a treatment for heart failure using a patient’s own bone marrow stem cells is recruiting participants at the first two study sites.
-
Brain Cancer Regression Shown with Engineered T-Cells
A patient treated with immune system cells genetically modified to attack his brain cancer reported regression of recurring tumors in the brain and spinal cord.
-
FDA Approves Spinal Muscular Atrophy Drug [Updated]
A drug to treat spinal muscular atrophy, a genetic disorder causing the wasting away of muscle tissue in children and adults, was approved for sale in the U.S.